• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Eli Lilly's Medicaid rebate payments under fire as whistleblower lawsuit heads to trial

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Mar 02, 2022 at 10:52: AM
via Eli Lilly is headed to trial over claims it skimped on Medicaid rebate payments.

U.S. District Judge Harry Leinenweber has shot down Lilly’s motion to end a 2014 whistleblower lawsuit, concluding that the Indianapolis-based pharma previously misled the Centers for Medicare & Medicaid Services (CMS) about the prices it charged distributors for its drugs.

article source
 




Top Bottom
Back
Quote